等温核酸増幅技術（INAAT）の世界市場レポート 2025年

等温核酸増幅技術（INAAT）市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.6％で75億1,000万米ドルに成長します。予測期間の成長は、パンデミック対策、抗菌剤耐性、環境モニタリング、腫瘍診断、世界ヘルスへの取り組みに起因すると考えられます。予測期間の主な動向には、多重化、小型化、デジタル検出、sample-to-answerシステム、遺伝子編集統合などがあります。

感染症および慢性疾患の罹患率の上昇は、等温核酸増幅技術（INAAT）市場拡大の重要な促進要因です。H.インフルエンザ菌、S.肺炎（呼吸器感染症）、N.淋菌、C.トラコマティス（性器感染症）、結核などの疾病は増加傾向にあり、等温核酸増幅技術（INAAT）のような診断ソリューションが求められています。世界保健機関（WHO）によると、毎年推定1,000万人が結核に罹患し、150万人が死亡しています。感染症や慢性疾患の蔓延が拡大していることが、等温核酸増幅技術市場の拡大に拍車をかけています。

ヘルスケアの研究開発を目的とした政府のイニシアチブは、等温核酸増幅技術市場の今後の成長を大きく後押しするものと思われます。これらのイニシアチブには、等温核酸増幅技術の支援を含む様々なヘルスケア問題に取り組むために政府機関によって開始された特定の行動、プログラム、政策が含まれます。2022年、英国の保健社会医療省（DHSC）は、ヘルスケアの研究と製造を促進するため、2億6,000万ポンド（2億7,065万米ドル）の資金拠出を発表しました。ビジネス・エネルギー・産業戦略省（BEIS）とDHSCによって設立されたこの資金は、NHS主導の医療研究、診断・治療のためのプライバシー保護プラットフォームの促進、英国におけるライフサイエンス製造の強化を目的としています。従って、医療研究開発に焦点を当てた政府の取り組みが等温核酸増幅技術市場を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界等温核酸増幅技術（INAAT） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の等温核酸増幅技術（INAAT）市場：成長率分析
• 世界の等温核酸増幅技術（INAAT）市場の実績：規模と成長, 2019-2024
• 世界の等温核酸増幅技術（INAAT）市場の予測：規模と成長, 2024-2029, 2034F
• 世界等温核酸増幅技術（INAAT）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の等温核酸増幅技術（INAAT）市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬
• 世界の等温核酸増幅技術（INAAT）市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• NASBA
• HAD
• 世界の等温核酸増幅技術（INAAT）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 感染症診断
• がん
• 世界の等温核酸増幅技術（INAAT）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• リファレンスラボ
• その他のエンドユーザー
• 世界の等温核酸増幅技術（INAAT）市場、楽器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブル機器
• ベンチトップ機器
• 世界の等温核酸増幅技術（INAAT）市場、試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素
• プライマーとプローブ
• 緩衝液およびその他の試薬

第7章 地域別・国別分析

• 世界の等温核酸増幅技術（INAAT）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の等温核酸増幅技術（INAAT）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 等温核酸増幅技術（INAAT）市場：競合情勢
• 等温核酸増幅技術（INAAT）市場：企業プロファイル
  • Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
  • biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
  • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
  • Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lucigen Corporation
• Quidel Corporation
• New England Biolabs Inc.
• NuGen
• Ustar Biotechnologies Ltd.
• Thermo Fisher Scientific Inc.
• BioHelix Corporation
• Meridian Bioscience Inc.
• Novartis AG
• Sharp Corporation
• Sony Corporation
• Panasonic Holdings Corporation
• Toshiba Corporation
• Rohm Co Ltd.
• PhilipsHologic-Gen-Probe

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 等温核酸増幅技術（INAAT）市場2029：新たな機会を提供する国
• 等温核酸増幅技術（INAAT）市場2029：新たな機会を提供するセグメント
• 等温核酸増幅技術（INAAT）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Isothermal nucleic acid amplification technology (INAAT) is a method employed for amplifying DNA samples. INAAT enables the amplification of DNA sequences from two different nucleic acid segments at a constant temperature.

The primary product types associated with isothermal nucleic acid amplification technology include instruments and reagents. Reagents are substances or compounds introduced into a system to induce a chemical reaction or to determine whether a reaction has occurred. Various technologies, such as NASBA and HAD, are used in this context and are typically applied in areas like blood screening, infectious disease diagnostics, and cancer-related analyses. The end users of this technology encompass hospitals, reference laboratories, and other institutions.

The isothermal nucleic acid amplification technology (INAAT) market research report is one of a series of new reports from The Business Research Company that provides isothermal nucleic acid amplification technology (INAAT) market statistics, including isothermal nucleic acid amplification technology (INAAT) industry global market size, regional shares, competitors with a isothermal nucleic acid amplification technology (INAAT) market share, detailed isothermal nucleic acid amplification technology (INAAT) market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (INAAT) industry. This isothermal nucleic acid amplification technology (INAAT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isothermal nucleic acid amplification technology (INAAT) market size has grown rapidly in recent years. It will grow from $3.94 billion in 2024 to $4.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to infectious disease diagnostics, point-of-care testing (poct), tuberculosis control, molecular diagnostics, emerging markets.

The isothermal nucleic acid amplification technology (INAAT) market size is expected to see rapid growth in the next few years. It will grow to $7.51 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to pandemic preparedness, antimicrobial resistance, environmental monitoring, oncology diagnostics, global health initiatives. Major trends in the forecast period include multiplexing, miniaturization, digital detection, sample-to-answer systems, gene editing integration.

The rising incidence of Infectious and Chronic Diseases is a significant driver behind the expansion of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. Diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are on the increase, demanding diagnostic solutions like isothermal nucleic acid amplification technology (INAAT). According to the World Health Organization (WHO), an estimated 10 million people contract tuberculosis every year, resulting in 1.5 million deaths. The growing prevalence of infectious and chronic diseases is a key factor fueling the expansion of the isothermal nucleic acid amplification technology market.

Government initiatives aimed at healthcare research and development are poised to significantly drive the growth of the isothermal nucleic acid amplification technology market in the future. These initiatives involve specific actions, programs, or policies launched by government entities to tackle various healthcare issues, including supporting isothermal nucleic acid amplification technology. In 2022, the UK's Department of Health and Social Care (DHSC) announced a £260 million ($270.65 million) funding commitment to foster healthcare research and manufacturing. This funding, established by the Department for Business, Energy and Industrial Strategy (BEIS) and DHSC, aims to facilitate NHS-led health research, privacy-preserving platforms for diagnostics and treatments, and bolster life sciences manufacturing in the UK. Hence, government initiatives focused on healthcare research and development are propelling the isothermal nucleic acid amplification technology market.

Nanostructures are increasingly integrated into in vitro diagnostics and in vitro rapid diagnostic tests (RDTs) to enhance existing tests' effectiveness and develop innovative diagnostic approaches for point-of-care applications. Nanostructures and nanotechnology employ nanoparticles to improve drug actions in treatments. Nanotechnology entails designing, characterizing, producing, and applying devices, structures, and systems by precisely manipulating size and shape at the nanometer scale. Several RDTs have been created for syphilis diagnosis, such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs enable patients to receive diagnoses at the point of care (POC).

Major companies operating in the isothermal nucleic acid amplification technology market are developing innovative solutions like the QIAstat-Dx syndromic testing solution to gain a competitive advantage. The QIAstat-Dx system is an integrated, multiplexed molecular testing platform that combines sample preparation, nucleic acid amplification, and detection within a single cartridge. For instance, in April 2023, Qiagen, a Netherlands-based company specializing in isothermal nucleic acid amplification technology (INAAT) for various applications, introduced the QIAstat-Dx syndromic testing solution. This system provides Ct (cycle threshold) values and access to amplification curves, allowing clinicians to monitor amplification progress and make well-informed diagnostic decisions.

In February 2023, Sherlock Biosciences, a U.S.-based biotechnology company, acquired Sense Biodetection for an undisclosed amount. This acquisition allows Sherlock to enhance its diagnostic capabilities by integrating Sense's LAMP-based technology with its advanced CRISPR methodologies, thereby improving the speed and accessibility of molecular testing. Sense Biodetection, a UK-based company, specializes in developing rapid, point-of-care diagnostic solutions that utilize isothermal nucleic acid amplification technology, particularly Loop-Mediated Isothermal Amplification (LAMP).

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market include Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2024. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the isothermal nucleic acid amplification technology (inaat) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isothermal nucleic acid amplification technology (inaat) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inaat) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isothermal nucleic acid amplification technology (inaat) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instrument; Reagent
• 2) By Technology: NASBA; HAD
• 3) By Application: Blood Screening; Infectious Disease Diagnostics; Cancer
• 4) By End-User: Hospital; Reference Laboratories; Other End-Users
• Subsegments:
• 1) By Instrument: Portable Instruments; Benchtop Instruments
• 2) By Reagent: Enzymes; Primers And Probes; Buffers And Other Reagents
• Companies Mentioned: Alere Inc.; biomeriux SA; Qiagen NV; Becton, Dickson & Company; Hologica Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics

3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends And Strategies

4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate Analysis
• 5.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Total Addressable Market (TAM)

6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

• 6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instrument
• Reagent
• 6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NASBA
• HAD
• 6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Screening
• Infectious Disease Diagnostics
• Cancer
• 6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Reference Laboratories
• Other End-Users
• 6.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Instruments
• Benchtop Instruments
• 6.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Primers and Probes
• Buffers and Other Reagents

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional And Country Analysis

• 7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 18.1. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 19.1. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 20.1. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 21.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 21.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 22.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 23.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 23.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 24.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 24.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 25.1. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 25.2. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 26.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 26.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 27.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 28.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 28.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market

• 29.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
• 29.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape And Company Profiles

• 30.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
• 30.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
  • 30.2.1. Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Other Major And Innovative Companies

• 31.1. Lucigen Corporation
• 31.2. Quidel Corporation
• 31.3. New England Biolabs Inc.
• 31.4. NuGen
• 31.5. Ustar Biotechnologies Ltd.
• 31.6. Thermo Fisher Scientific Inc.
• 31.7. BioHelix Corporation
• 31.8. Meridian Bioscience Inc.
• 31.9. Novartis AG
• 31.10. Sharp Corporation
• 31.11. Sony Corporation
• 31.12. Panasonic Holdings Corporation
• 31.13. Toshiba Corporation
• 31.14. Rohm Co Ltd.
• 31.15. PhilipsHologic-Gen-Probe

32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

34. Recent Developments In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

35. Isothermal Nucleic Acid Amplification Technology (INAAT) Market High Potential Countries, Segments and Strategies

• 35.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer